Loading, Please Wait...
In 2015, the U.S. Market for Assisted Reproduction Technology Devices Was Valued at Over $30 Million; Clinics & Labs That Purchase Products have Been Going Through a Period of Mergers and Acquisitions
VANCOUVER, BC --(Marketwired - March 14, 2016) - According to a new series of reports on the U.S. urological device market by iData Research (www.idataresearch.com), the price sensitivity of the assisted reproduction technology (ART) market will moderate its future growth. ART procedures are often an expensive out-of-pocket expenditure for couples. The ART market includes oocyte retrieval needles, micropipettes, embryo transfer catheters and reproduction media. The largest segment in the ART device market in 2015 was reproduction media, which accounted for nearly 50% of the market value.
Reproductive media products are a combination of salts and nutrient substances and are utilized at several steps of the in-vitro fertilization process. Reproduction media consists of culture media, sperm preparation media, manipulation devices and freeze/thaw media. One or multiple pieces of media can be needed depending on the number of assisted reproduction treatment cycles required, leading to higher unit sales and average selling prices (ASP) than other products in this market. Each cycle involves one round of in-vitro fertilization, which may or may not be successful. Should it fail, the couple can attempt again as needed.
The freeze/thaw ASP is expected to increase as a result of vitrification, an expensive treatment, becoming more popular over traditional cryopreservation. Sperm preparation media is the largest segment in the reproduction media market due to its higher unit sales than the other products. Transfer catheters are also highly dependent on the number of cycles performed, which is contingent on the economic situation as well as the increasing age of first time mothers. Unit sales will increase at the same rate as the overall market, since unit sales are dependent on the number of reproduction cycles.
Competitive pricing has resulted in a climate of depreciating ASP for micropipettes used for diluting and manipulating the oocyte and sperm. Due to the bulk nature of the product, this decline will be more noticeable at the point of sale where they are often sold in packs of 10 or more. Although the ASP is declining, it is offset by positive unit sales growth, allowing the overall value of the micropipette market to increase.
"The market now has a limited number of major stakeholders that manage purchasing for a large majority of clinics and labs," explains Dr. Kamran Zamanian, CEO of iData. "This has caused consensus based and centralized purchasing that in turn has put pressure on ASPs, causing them to either decrease or remain flat."
In 2015, Cooper Surgical controlled roughly half of the assisted reproduction market in the United States. Their acquisition of ORIGIO in 2012 provided them with a vast array of products in the ART market. They offer multiple ART products including, those for fertilization, culture, transfer, and for the freezing and thawing of embryos. Also thanks to this acquisition, Cooper now offers both single and double lumen oocyte retrieval needles and transfer catheters.
Cook Medical was the second leading competitor in 2015 with over 40% of the retrieval needle market. Cook has over 15 different retrieval needles available in various product lines. They also provide roughly 20% of the embryo transfer catheters in the market as well as nearly 30% of the micropipettes with its line of more than ten Cook® branded micropipettes. Other competitors in the assisted reproduction technology market include Irvine Scientific, Vitrolife, Rocket Medical, InVitroCare, LifeGlobal, Smiths Medical, and Sunlight Medical.
For Further Information
More on the assisted reproduction technology market in the United States can be found in a report suite published by iData Research entitled the U.S. Market Report Suite for Gynecological Devices. The suite covers reports on the following markets: Assisted Reproduction Technology Devices, Global Endometrial Ablation, Resectoscopic Endometrial Ablation & Resection Devices, Uterine Fibroid Embolization Devices, Hysteroscopes, Colposcopes, Female Sterilization Devices, Female Urinary Incontinence Slings, Pelvic Floor Electrical Stimulation Devices, Fluid Management Devices, Pelvic Organ Prolapse Repair Devices, and HSG Catheters.
The iData report series on gynecological devices covers the U.S., and 15 countries in Europe. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about gynecological device market data or procedure data, register online or email us at firstname.lastname@example.org for a U.S. Market Report Suite for Gynecological Devices brochure and synopsis.
About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.
iData Research Inc.
604-266-6933 Ext. 205